Paumgartner, Gustav

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

Beuers, U., Spengler, U., Kruis, W., Aydemir, Ü., Wiebecke, B., Heldwein, W., Weinzierl, M., Pape, G. R., Sauerbruch, T., & Paumgartner, G. (1992) · Hepatology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 448

Increased serum deoxycholic acid levels in men with colorectal adenomas

Bayerdörffer, E., Mannes, G. A., Richter, W. O., Ochsenkühn, T., Wiebecke, B., Köpcke, W., & Paumgartner, G. (1993) · Gastroenterology

Colorectal Cancer Screening and DetectionCancer, Lipids, and Metabolism

Cited by 234

New therapeutic concepts in bile acid transport and signaling for management of cholestasis

Trauner, M., Fuchs, C. D., Halilbasic, E., & Paumgartner, G. (2017) · Hepatology

Drug Transport and Resistance MechanismsLiver Diseases and Immunity

Cited by 227

Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis

Baghdasaryan, A., Fuchs, C. D., Österreicher, C. H., Lemberger, U. J., Halilbasic, E., Påhlman, I., Graffner, H., Krones, E., Fickert, P., Wahlström, A., et al. (2016) · Journal of Hepatology

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 187

Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.

Bayerdörffer, E., Mannes, G. A., Ochsenkühn, T., Dirschedl, P., Wiebecke, B., & Paumgartner, G. (1995) · Gut

Colorectal Cancer Screening and DetectionGut microbiota and health

Cited by 146

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2−/− mice by modulating composition, signalling and excretion of faecal bile acids

Fuchs, C. D., Paumgartner, G., Mlitz, V., Kunczer, V., Halilbasic, E., Leditznig, N., Wahlström, A., Ståhlman, M., Thüringer, A., Kashofer, K., et al. (2018) · Gut

Liver Diseases and ImmunityDrug Transport and Resistance Mechanisms

Cited by 76